Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 10, 2025 Filed Mar 13, 2025 01:30 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
Exercise / conversionMarket Share Units · Derivative | 4,886 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000063 · wk-form4_1741829424.xml · derivative · entry 13 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 4,886 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2021. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:30 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
Tax withholdingCommon Stock, $0.10 par value | 9,232 | $63.11 | $582,631.52 |
DisclosureSEC source: 0000014272-25-000063 · wk-form4_1741829424.xml · nonDerivative · entry 12 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,263.486 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:30 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
OtherCommon Stock, $0.10 par value | 10,545 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000063 · wk-form4_1741829424.xml · nonDerivative · entry 11 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,495.486 F7 · shares: Adjustment to award based on the performance factor applied in accordance with the terms of the award and certification of performance results by the Board. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:30 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
Exercise / conversionCommon Stock, $0.10 par value | 28,593 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000063 · wk-form4_1741829424.xml · nonDerivative · entry 10 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,040.486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Amount represents distribution of performance shares earned under the 2022-2024 Long-Term Performance Award. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:30 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
Tax withholdingCommon Stock, $0.10 par value | 2,484 | $63.11 | $156,765.24 |
DisclosureSEC source: 0000014272-25-000063 · wk-form4_1741829424.xml · nonDerivative · entry 9 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,447.486 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:30 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
OtherCommon Stock, $0.10 par value | 998 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000063 · wk-form4_1741829424.xml · nonDerivative · entry 8 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,931.486 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:30 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
Exercise / conversionCommon Stock, $0.10 par value | 5,854 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000063 · wk-form4_1741829424.xml · nonDerivative · entry 7 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,929.486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2023. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:30 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
Tax withholdingCommon Stock, $0.10 par value | 2,013 | $63.11 | $127,040.43 |
DisclosureSEC source: 0000014272-25-000063 · wk-form4_1741829424.xml · nonDerivative · entry 6 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,075.486 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:30 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
OtherCommon Stock, $0.10 par value | 831 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000063 · wk-form4_1741829424.xml · nonDerivative · entry 5 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,088.486 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:30 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
Exercise / conversionCommon Stock, $0.10 par value | 4,765 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000063 · wk-form4_1741829424.xml · nonDerivative · entry 4 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,919.486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2022. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:30 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
Tax withholdingCommon Stock, $0.10 par value | 2,327 | $63.11 | $146,856.97 |
DisclosureSEC source: 0000014272-25-000063 · wk-form4_1741829424.xml · nonDerivative · entry 3 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,154.486 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:30 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
OtherCommon Stock, $0.10 par value | 337 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000063 · wk-form4_1741829424.xml · nonDerivative · entry 2 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,481.486 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:30 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
Exercise / conversionCommon Stock, $0.10 par value | 4,886 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000063 · wk-form4_1741829424.xml · nonDerivative · entry 1 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,818.486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2021. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Holzer Phil MSVP and Controller
|
GrantPerformance Shares · Derivative | 7,368 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000064 · wk-form4_1741829459.xml · derivative · entry 18 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,368 Underlying: Common Stock, $0.10 par value · 7,368 shares Expires 2028-03-10 F13 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2028, subject to certification of performance results by the Board. F13 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2028, subject to certification of performance results by the Board. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Holzer Phil MSVP and Controller
|
Exercise / conversionPerformance Shares · Derivative | 4,861 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000064 · wk-form4_1741829459.xml · derivative · entry 17 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 4,861 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_price: Each performance share converted into one share of common stock upon distribution in the first quarter of 2025 in accordance with the terms of the award and certification of performance results by the Board. F6 · derivative.exercise_date: Amount represents distribution of performance shares earned under the 2022-2024 Long-Term Performance Award. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Holzer Phil MSVP and Controller
|
GrantMarket Share Units · Derivative | 4,912 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000064 · wk-form4_1741829459.xml · derivative · entry 16 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,912 Underlying: Common Stock, $0.10 par value · 4,912 shares Expires 2028-03-10 F10 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout. F11 · derivative.exercise_date: These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Holzer Phil MSVP and Controller
|
Exercise / conversionMarket Share Units · Derivative | 768 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000064 · wk-form4_1741829459.xml · derivative · entry 15 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,539 Underlying: Common Stock, $0.10 par value · 768 shares Expires 2027-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F5 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2023. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Holzer Phil MSVP and Controller
|
Exercise / conversionMarket Share Units · Derivative | 810 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000064 · wk-form4_1741829459.xml · derivative · entry 14 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 811 Underlying: Common Stock, $0.10 par value · 810 shares Expires 2026-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2022. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Holzer Phil MSVP and Controller
|
Exercise / conversionMarket Share Units · Derivative | 701 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000064 · wk-form4_1741829459.xml · derivative · entry 13 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 701 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2021. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Holzer Phil MSVP and Controller
|
Tax withholdingCommon Stock, $0.10 par value | 1,110 | $63.11 | $70,052.10 |
DisclosureSEC source: 0000014272-25-000064 · wk-form4_1741829459.xml · nonDerivative · entry 12 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,967 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Holzer Phil MSVP and Controller
|
OtherCommon Stock, $0.10 par value | 1,793 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000064 · wk-form4_1741829459.xml · nonDerivative · entry 11 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,077 F7 · shares: Adjustment to award based on the performance factor applied in accordance with the terms of the award and certification of performance results by the Board. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Holzer Phil MSVP and Controller
|
Exercise / conversionCommon Stock, $0.10 par value | 4,861 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000064 · wk-form4_1741829459.xml · nonDerivative · entry 10 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Amount represents distribution of performance shares earned under the 2022-2024 Long-Term Performance Award. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Holzer Phil MSVP and Controller
|
Tax withholdingCommon Stock, $0.10 par value | 231 | $63.11 | $14,578.41 |
DisclosureSEC source: 0000014272-25-000064 · wk-form4_1741829459.xml · nonDerivative · entry 9 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,009 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Holzer Phil MSVP and Controller
|
OtherCommon Stock, $0.10 par value | 131 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000064 · wk-form4_1741829459.xml · nonDerivative · entry 8 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,240 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Holzer Phil MSVP and Controller
|
Exercise / conversionCommon Stock, $0.10 par value | 768 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000064 · wk-form4_1741829459.xml · nonDerivative · entry 7 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,371 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2023. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Holzer Phil MSVP and Controller
|
Tax withholdingCommon Stock, $0.10 par value | 242 | $63.11 | $15,272.62 |
DisclosureSEC source: 0000014272-25-000064 · wk-form4_1741829459.xml · nonDerivative · entry 6 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,603 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Holzer Phil MSVP and Controller
|
OtherCommon Stock, $0.10 par value | 141 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000064 · wk-form4_1741829459.xml · nonDerivative · entry 5 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,845 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Holzer Phil MSVP and Controller
|
Exercise / conversionCommon Stock, $0.10 par value | 810 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000064 · wk-form4_1741829459.xml · nonDerivative · entry 4 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2022. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Holzer Phil MSVP and Controller
|
Tax withholdingCommon Stock, $0.10 par value | 237 | $63.11 | $14,957.07 |
DisclosureSEC source: 0000014272-25-000064 · wk-form4_1741829459.xml · nonDerivative · entry 3 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,176 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Holzer Phil MSVP and Controller
|
OtherCommon Stock, $0.10 par value | 48 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000064 · wk-form4_1741829459.xml · nonDerivative · entry 2 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,413 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Holzer Phil MSVP and Controller
|
Exercise / conversionCommon Stock, $0.10 par value | 701 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000064 · wk-form4_1741829459.xml · nonDerivative · entry 1 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2021. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
LEUNG SANDRAEVP, General Counsel
|
GrantPerformance Shares · Derivative | 37,155 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · derivative · entry 20 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,155 Underlying: Common Stock, $0.10 par value · 37,155 shares Expires 2028-03-10 F15 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2028, subject to certification of performance results by the Board. F15 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2028, subject to certification of performance results by the Board. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
LEUNG SANDRAEVP, General Counsel
|
Exercise / conversionPerformance Shares · Derivative | 32,096 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · derivative · entry 19 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 32,096 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_price: Each performance share converted into one share of common stock upon distribution in the first quarter of 2025 in accordance with the terms of the award and certification of performance results by the Board. F6 · derivative.exercise_date: Amount represents distribution of performance shares earned under the 2022-2024 Long-Term Performance Award. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
LEUNG SANDRAEVP, General Counsel
|
GrantMarket Share Units · Derivative | 24,770 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · derivative · entry 18 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,770 Underlying: Common Stock, $0.10 par value · 24,770 shares Expires 2028-03-10 F12 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout. F13 · derivative.exercise_date: These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
LEUNG SANDRAEVP, General Counsel
|
Exercise / conversionMarket Share Units · Derivative | 5,415 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · derivative · entry 17 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,833 Underlying: Common Stock, $0.10 par value · 5,415 shares Expires 2027-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F5 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2023. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
LEUNG SANDRAEVP, General Counsel
|
Exercise / conversionMarket Share Units · Derivative | 5,349 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · derivative · entry 16 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,351 Underlying: Common Stock, $0.10 par value · 5,349 shares Expires 2026-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2022. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
LEUNG SANDRAEVP, General Counsel
|
Exercise / conversionMarket Share Units · Derivative | 5,858 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · derivative · entry 15 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 5,858 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2021. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
LEUNG SANDRAEVP, General Counsel
|
Tax withholdingCommon Stock, $0.10 par value | 10,363 | $63.11 | $654,008.93 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 12 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 364,296.333 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
LEUNG SANDRAEVP, General Counsel
|
OtherCommon Stock, $0.10 par value | 11,837 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 11 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 374,659.333 F7 · shares: Adjustment to award based on the performance factor applied in accordance with the terms of the award and certification of performance results by the Board. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
LEUNG SANDRAEVP, General Counsel
|
Exercise / conversionCommon Stock, $0.10 par value | 32,096 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 10 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 386,496.333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Amount represents distribution of performance shares earned under the 2022-2024 Long-Term Performance Award. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
LEUNG SANDRAEVP, General Counsel
|
Tax withholdingCommon Stock, $0.10 par value | 2,298 | $63.11 | $145,026.78 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 9 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 354,400.333 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
LEUNG SANDRAEVP, General Counsel
|
OtherCommon Stock, $0.10 par value | 923 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 8 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 356,698.333 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
LEUNG SANDRAEVP, General Counsel
|
Exercise / conversionCommon Stock, $0.10 par value | 5,415 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 7 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 357,621.333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2023. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
LEUNG SANDRAEVP, General Counsel
|
Tax withholdingCommon Stock, $0.10 par value | 2,259 | $63.11 | $142,565.49 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 6 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 352,206.333 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
LEUNG SANDRAEVP, General Counsel
|
OtherCommon Stock, $0.10 par value | 933 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 5 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 354,465.333 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
LEUNG SANDRAEVP, General Counsel
|
Exercise / conversionCommon Stock, $0.10 par value | 5,349 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 4 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 355,398.333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2022. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
LEUNG SANDRAEVP, General Counsel
|
Tax withholdingCommon Stock, $0.10 par value | 2,790 | $63.11 | $176,076.90 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 3 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,049.333 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
LEUNG SANDRAEVP, General Counsel
|
OtherCommon Stock, $0.10 par value | 404 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 2 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 352,839.333 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
LEUNG SANDRAEVP, General Counsel
|
Exercise / conversionCommon Stock, $0.10 par value | 5,858 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 1 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 353,243.333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2021. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
GrantPerformance Shares · Derivative | 7,531 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000065 · wk-form4_1741829503.xml · derivative · entry 18 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,531 Underlying: Common Stock, $0.10 par value · 7,531 shares Expires 2028-03-10 F13 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2028, subject to certification of performance results by the Board. F13 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2028, subject to certification of performance results by the Board. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.